• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
78,099.89 913.02
( 1.18%)
Global Indices
Nasdaq
52,569.33 -110.31
(-0.21%)
Dow Jones
7,555.54 -37.86
(-0.50%)
Hang Seng
63,887.74 -2,947.80
(-4.41%)
Nikkei 225
10,555.24 39.32
(0.37%)
Forex
USD-INR
96.26 0.11
(0.12%)
EUR-INR
110.12 0.41
(0.38%)
GBP-INR
129.49 0.88
(0.69%)
JPY-INR
0.59 0.00
(0.14%)

EQUITY - MARKET SCREENER

Vivimed Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532660
INE526G01021
0.9167078
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VIVIMEDLAB
0
42.04
EPS(TTM)
Face Value()
Div & Yield %
0
2
0
 
( Cr)
ParticularsDec 2025 ( Cr)Sep 2025 ( Cr)Jun 2025 ( Cr)
Gross Sales11.6318.6617.94
Other Operating Income0.000.000.00
Other Income 0.000.160.36
Total Income11.6318.8218.30
Total Expenditure 22.8519.9818.48
PBIDT-11.22-1.16-0.18
Interest 0.941.600.52
PBDT-12.16-2.76-0.70
Depreciation4.404.684.80
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax0.000.000.00
Reported Profit After Tax-16.57-7.45-5.50
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-16.57-7.45-5.50
EPS (Unit Curr.)-2.00-0.90-0.66
EPS (Adj) (Unit Curr.)-2.00-0.90-0.66
Calculated EPS (Unit Curr.)-2.00-0.90-0.66
Calculated EPS (Adj) (Unit Curr.)-2.00-0.90-0.66
Calculated EPS (Ann.) (Unit Curr.)-7.99-3.59-2.65
Calculated EPS (Adj) (Ann.) (Unit Curr.)-7.99-3.59-2.65
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity16.5816.5816.58
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)-96.47-6.22-1.00
PBDTM(%)-104.56-14.79-3.90
PATM(%)-142.48-39.92-30.66